| James Kimo Jandoc, OMT, LMT, STMS | |
|
1610 Grover St Ste C3, Lynden, WA 98264 | |
| (360) 510-4630 | |
| (360) 935-9731 |
| Full Name | James Kimo Jandoc |
|---|---|
| Gender | Male |
| Speciality | Massage Therapist |
| Location | 1610 Grover St Ste C3, Lynden, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255649869 | NPI | - | NPPES |
| 0152465 | Other | WA | WASHINGTON STATE DEPARTMENT OF LABOR AND INDUSTRY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | MA00015681 (Washington) | Secondary |
| 225700000X | Massage Therapist | MA00015681 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| James Kimo Jandoc, OMT, LMT, STMS 1668 Westview Cir, Lynden, WA 98264-8578 Ph: (360) 510-4630 | James Kimo Jandoc, OMT, LMT, STMS 1610 Grover St Ste C3, Lynden, WA 98264 Ph: (360) 510-4630 |
News Archive
When it comes to removing very dilute concentrations of pollutants from water, existing separation methods tend to be energy- and chemical-intensive. Now, a new method developed at MIT could provide a selective alternative for removing even extremely low levels of unwanted compounds.
A selection of health policy stories from California, Missouri, Maine, Michigan, North Carolina, Texas and Georgia.
The Miriam Hospital is actively recruiting local participants for a U.S. clinical trial of the Parachute device for treating heart failure. The study is focused on determining if the new minimally invasive catheter-based device can slow the progression of heart failure, reduce repeat hospitalizations and death, and significantly improve quality of life for patients who experience enlargement of the left ventricle after a heart attack.
Bad cholesterol, known as LDL is known to be sticky but this ultra –bad called MGmin-LDL is found to be stickier meaning it's more likely to attach to arterial walls. This is more dangerous because when LDL attaches to artery walls it forms fatty plaques that cause coronary heart disease (CHD). As fatty plaques grow, they narrow the arteries and reduce blood flow and also may trigger a stroke or heart attack. CHD is the most common type of heart disease and kills almost 450,000 Americans each year.
The latest research has revealed that a new drug for treating people with an irregular heartbeat has fewer side effects than the standard treatment and is just as good at cutting the risk of stroke. Rivaroxaban, which is easier for people to take, is as effective as warfarin at preventing blood clots and thus lowering the risk of stroke for patients with atrial fibrillation say researchers.
› Verified 1 days ago